Nearly the end of March and management are keeping a very low...

Nearly the end of March and management are keeping a very low profile. Why is that, I wonder?

It could be that the three internal DEP programs are complete or near completion, and the excellent results are being prepared for presentation to a number of very interested pharma companies. Hopefully management are ZOOMING around the world, negotiating the best possible deal for the loyal shareholders.
Of course, all other activities need to take a back seat while these high value negotiations take place. That is understandable !
By the end of June the shareholders can expect to see some deals that propel the share price upwards and annual dividend payments commence.

Alternatively, management have buggered off on an extended Easter holiday, leaving the graduate trainee in charge, because there is nothing happening at all in Abbotsford HQ.